OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update
Vivek P. Chavda, Rajashri Bezbaruah, Sheetal Dolia, et al.
Process Biochemistry (2023) Vol. 127, pp. 66-81
Open Access | Times Cited: 16
Vivek P. Chavda, Rajashri Bezbaruah, Sheetal Dolia, et al.
Process Biochemistry (2023) Vol. 127, pp. 66-81
Open Access | Times Cited: 16
Showing 16 citing articles:
Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design
Lalitkumar K. Vora, Amol D. Gholap, Keshava Jetha, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1916-1916
Open Access | Times Cited: 360
Lalitkumar K. Vora, Amol D. Gholap, Keshava Jetha, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1916-1916
Open Access | Times Cited: 360
Protein subunit vaccines: Promising frontiers against COVID-19
Vivek P. Chavda, Eswara Naga Hanuma Kumar Ghali, Pankti C. Balar, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 761-782
Closed Access | Times Cited: 15
Vivek P. Chavda, Eswara Naga Hanuma Kumar Ghali, Pankti C. Balar, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 761-782
Closed Access | Times Cited: 15
Next-generation treatments: Immunotherapy and advanced therapies for COVID-19
Jenny Andrea Arévalo-Romero, Sandra M. Chingaté-López, Bernardo Camacho, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26423-e26423
Open Access | Times Cited: 8
Jenny Andrea Arévalo-Romero, Sandra M. Chingaté-López, Bernardo Camacho, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26423-e26423
Open Access | Times Cited: 8
Expansion of SARS-CoV-2 mutations in patient with B-cell lymphoma and rare combination of ACE2, TLR4, DDX58 and IFIH1 variations: A retrospective analysis of the virus-host interplay
Angelina Trifonova, Adelina Yosifova, Atanas Syarov, et al.
Clinical Immunology Communications (2025)
Open Access
Angelina Trifonova, Adelina Yosifova, Atanas Syarov, et al.
Clinical Immunology Communications (2025)
Open Access
Regulatory processes involved in clinical trials and intellectual property rights around vaccine development
Nimeet Desai, Shreya Pande, Amol D. Gholap, et al.
Elsevier eBooks (2024), pp. 279-309
Closed Access | Times Cited: 4
Nimeet Desai, Shreya Pande, Amol D. Gholap, et al.
Elsevier eBooks (2024), pp. 279-309
Closed Access | Times Cited: 4
Hyperimmune Plasma and Immunoglobulins against COVID-19: A Narrative Review
Massimo Franchini, Daniele Focosi
Life (2024) Vol. 14, Iss. 2, pp. 214-214
Open Access | Times Cited: 2
Massimo Franchini, Daniele Focosi
Life (2024) Vol. 14, Iss. 2, pp. 214-214
Open Access | Times Cited: 2
Blood filtering system for COVID-19 management: novel modality of the cytokine storm therapeutics
Vivek P. Chavda, Nidhi Raval, Soham Sheta, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Vivek P. Chavda, Nidhi Raval, Soham Sheta, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
SARS‐CoV‐2 neutralising antibody therapies: Recent advances and future challenges
Mingtao Liu, Zhiman Liang, Zhangkai J. Cheng, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 5
Closed Access | Times Cited: 4
Mingtao Liu, Zhiman Liang, Zhangkai J. Cheng, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 5
Closed Access | Times Cited: 4
Simple prediction of COVID-19 convalescent plasma units with high levels of neutralization antibodies
Katerina Jazbec, Mojca Jež, Klemen Žiberna, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 3
Katerina Jazbec, Mojca Jež, Klemen Žiberna, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 3
Temporal and spatial analysis of COVID-19 incidence hotspots in Pakistan: A spatio-statistical approach
Nayab Arif, Shakeel Mahmood
Spatial and Spatio-temporal Epidemiology (2023) Vol. 47, pp. 100603-100603
Closed Access | Times Cited: 2
Nayab Arif, Shakeel Mahmood
Spatial and Spatio-temporal Epidemiology (2023) Vol. 47, pp. 100603-100603
Closed Access | Times Cited: 2
Parenteral vaccine delivery
Keshava Jetha, Niva Rani Gogoi, Anup Kumar, et al.
Elsevier eBooks (2024), pp. 167-205
Closed Access
Keshava Jetha, Niva Rani Gogoi, Anup Kumar, et al.
Elsevier eBooks (2024), pp. 167-205
Closed Access
Personalized vaccines, novel vaccination technologies, and future prospects
Srivatsa Surya Vasudevan, Tiba Yamin Kandrikar, Adil Ali Sayyed, et al.
Elsevier eBooks (2024), pp. 225-242
Closed Access
Srivatsa Surya Vasudevan, Tiba Yamin Kandrikar, Adil Ali Sayyed, et al.
Elsevier eBooks (2024), pp. 225-242
Closed Access
Evaluation of Neutralizing Capacity of Tixagevimab plus Cilgavimab (AZD7442) against Different SARS‐CoV‐2 Variants: A Case Report Study with Comparison to a Vaccinated Population
Constant Gillot, Jean‐Louis Bayart, Vincent Maloteau, et al.
Case Reports in Infectious Diseases (2024) Vol. 2024, Iss. 1
Open Access
Constant Gillot, Jean‐Louis Bayart, Vincent Maloteau, et al.
Case Reports in Infectious Diseases (2024) Vol. 2024, Iss. 1
Open Access
Development of a nomogram for high antibody titre of COVID-19 convalescent plasma
Shichun Wang, Jie Yan, Min-Sun Song, et al.
Epidemiology and Infection (2024) Vol. 152
Open Access
Shichun Wang, Jie Yan, Min-Sun Song, et al.
Epidemiology and Infection (2024) Vol. 152
Open Access
Harnessing Antiviral Peptides as Means for SARS-CoV-2 Control
Khatereh Zarkesh, Mohsen Akbarian, Lobat Tayebi, et al.
COVID (2023) Vol. 3, Iss. 7, pp. 975-986
Open Access | Times Cited: 1
Khatereh Zarkesh, Mohsen Akbarian, Lobat Tayebi, et al.
COVID (2023) Vol. 3, Iss. 7, pp. 975-986
Open Access | Times Cited: 1
Evaluation of neutralizing capacity of tixagevimab plus cilgavimab: a case-series study with comparison to a vaccinated population
Constant Gillot, Jean‐Louis Bayart, Vincent Maloteau, et al.
Research Square (Research Square) (2023)
Open Access
Constant Gillot, Jean‐Louis Bayart, Vincent Maloteau, et al.
Research Square (Research Square) (2023)
Open Access
